The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
For approximately €76.8mm ($60mm) (including assets, fees,
and earn-outs), bioMerieux has sold its hemostasis product
line to diagnostic testing company Trinity Biotech PLC . (May)
Along with a wide range of reagents that analyze blood clotting parameters, Trinity gets the MDA hemostasis and thrombosis analyzer,...